regulatory functions in the small and large intestine, provided both by
bioactive peptides and commensal microorganisms, which might be
involved in desensitization to food allergens.
In order to understand the mechanism by which food peptides
confer protection against established food allergy, we subjected mice
sensitized to EW to OIT with intact and hydrolysed EW. Changes in the
microbiota, generation of barrier-protective responses in the small and
large intestine and stimulation of a regulatory environment in non-
lymphoid and lymphoid tissues were studied. The results showed that
OIT with peptides resolved allergic symptoms and modulated the mi-
crobial alterations that accompanied sensitization. The health benefits
of peptide OIT were associated to vitamin A metabolism and develop-
ment of innate and adaptive cells that depend on RORγt for their
transcriptional regulation.
2. Materials and methods
2.1. Materials
Whole EW hydrolysed with pepsin (EP) was used as OIT, instead of
hydrolysed ovalbumin, because of its lower cost and ease of production
for larger scale uses. EW was obtained from fresh hen eggs. Hydrolysis
was conducted with 172 U/mg of protein of porcine pepsin (EC
3.4.23.1, 3440 U/mg, Sigma-Aldrich, St. Louis, MO, USA), at pH 1.5
and 37 °C for 24 h. The hydrolysate was neutralized to pH 7.0, heated at
95 °C for 15 min, centrifuged (5000g, 4 °C, 10 min) and lyophilized. The
absence of lipopolysaccharide was confirmed (Pierce®LAL, Thermo
scientific, Waltham, USA) and the protein content was analysed by the
Kjeldahl method.
2.2. Protocols in mice
Six week-old female BALB/c mice (Charles River Laboratories, Saint
Germain sur ĺArbresle, Rhône, France) were distributed in 5 groups (5
per group). Three groups were sensitized to EW by the intragastric
administration of 5 mg of EW on a protein basis and 10 μg of cholera
toxin (CT, List Biologicals, Campbell, CA, USA), during 3 successive
days on the first week and once per week for the subsequent 5 weeks (Li
et al., 2000). Sham-sensitized mice received CT and naïve mice just
received PBS. One week after, 2 groups of EW-sensitized mice were
administered intragastrically the amount equivalent to 5 mg of protein
of EW or EP, 3 times per week during 3 weeks. Mice from the other EW-
sensitized group, the sham-sensitized group and the naïve group were
administered PBS. Three days after, mice from all groups were in-
tragastrically challenged with 50 mg (on a protein basis) of EW. Thirty
min apart, anaphylaxis was evaluated by scoring clinical signs and
rectal temperature and 3 h later, mice were euthanized by CO
2
in-
halation (Pablos-Tanarro, Lozano-Ojalvo, Molina, & López-Fandiño,
2018).
In order to assess whether oral treatment with EW or EP could have
any direct impact on the caecal microbiota and its metabolism,
12 week-old naïve mice distributed in 3 groups (5 per group) were
administered PBS or 5 mg of protein of EW or EP, 3 times per week
during 3 weeks, as above, and euthanized 3 days later.
Serum levels of EW-specific IgE and IgG1, and mouse mast cell
protease-1 (mMCP-1) were quantified by ELISA (Pablos-Tanarro et al.,
2018). The caecal content was removed and stored at -80 °C. Duodenum
and colon segments and MLNs were preserved in storage buffer (Ma-
cherey-Nagel Gmbh & Co., Düren, Germany) at -80 °C for gene ex-
pression analyses. Spleen cells were isolated for flow cytometry as
previously described (Lozano-Ojalvo et al., 2017).
All protocols involving animals followed the European legislation
(Directive 2010/63/EU) and were approved by Comunidad de Madrid
(Ref PROEX 089/15).
2.3. Microbiological analyses
The caecal content was suspended in 0.1% peptone solution with
0.85% NaCl and centrifuged (10000g, 4 °C, 5 min). Pellets were used for
DNA extraction (Moles et al., 2013), and supernatants for short chain
fatty acid (SCFA) analysis (Requena et al., 2017). Quantitative PCR
(qPCR) was performed using SYBR green methodology in a ViiA7 Real-
Time PCR System (Life Technologies, Carlsbad, CA, USA), as shown in
Supplementary Table S1. SCFAs were analysed by HPLC (Jasco, Tokyo,
Japan) with a Rezex ROA column (Phenomenex, Macclesfield, UK) and
detection at 210 nm (Sanz et al., 2005).
2.4. Gene expression
Total RNA from duodenum, colon and MLNs was isolated using
NucleoSpin RNA Kit (Macherey-Nagel Gmbh & Co., Düren, Germany)
and cDNA was synthetized with PrimeScript RT kit (TaKaRa Bio Inc.,
Shiga, Japan). Conditions for qPCR are shown in Supplementary Table
S2. Relative gene expression was calculated by normalizing data to the
expression of the reference gene Actb, using either the sham-sensitized
or the naïve group as calibrators (Livak & Schmittgen, 2001).
2.5. Flow cytometry of T cells
Isolated splenocytes were recovered in PBS containing 2% fetal
bovine serum and 1 mM EDTA. Fc receptors were blocked using anti-
CD16/CD32 (clone 2.4G2, BD Biosciences) and live cells determined
with LIVE/DEAD®Kit (Thermo Fisher Scientific, Walthman, USA).
Samples were stained with the antibodies listed in Supplementary Table
S3 and analysed as shown in Supplementary Figure S1. Cells were ac-
quired with a Gallios flow cytometer (Beckman Coulter, Krefeld,
Germany) and analyses were performed with FlowJo for windows
(version 7.6.5).
2.6. Statistical analyses
Results are presented as means ± SEM, except for clinical signs,
which are expressed as medians. Differences were determined by one-
way ANOVA followed by Tukey post-hoc test, except for clinical signs
and relative gene expression data, which were evaluated by Mann-
Whitney Utest. P< 0.05 was considered statistically significant.
Analyses were performed with GraphPad Prism v5 (GraphPad Software,
San Diego, USA).
3. Results
3.1. Immunotherapy with peptides promotes oral tolerance and reverses
microbial alterations in mice sensitized to egg white with the aid of cholera
toxin
Administration of EP to EW-sensitized mice prevented anaphylaxis
and inhibited the release of mast cell mediators (mMCP-1) upon in-
tragastric challenge with the allergen (Supplementary Figure S2).
However, mice administered EW experienced similar clinical signs and
body temperature drops than the non-treated animals, although serum
levels of mMCP-1 were significantly lower. The improved condition of
mice treated with EP was accompanied by a reduction in the con-
centration of circulating EW-specific IgE and IgG1 (Supplementary
Figure S3).
Sensitization to EW using CT as adjuvant gave rise to decreases in
the abundance of total caecal bacteria, Clostridium leptum,
Ruminococcus,Roseburia and Blautia coccoides/Eubacterium rectale,
while Akkermansia was enhanced (Fig. 1). Administration of CT alone
decreased Enterobacteriaceae and Bacteroides and increased Bifido-
bacterium. In this respect, even if CT is broadly used as a Th2-driving
agent to induce sensitization in mice and it has been recognized that the
D. Lozano-Ojalvo et al. Journal of Functional Foods 52 (2019) 204–211
205